Roche, Apotex Drop One Patent In Spat Over Boniva
Hoffmann-La Roche Inc. and Apotex Inc. have dropped all claims and counterclaims related to one patent at the center of a fight over the osteoporosis drug Boniva....To view the full article, register now.
Already a subscriber? Click here to view full article